Contingency Management in Opioid Substitution Treatment

被引:2
|
作者
Specka, M. [1 ]
Boening, A. [1 ]
Scherbaum, N. [1 ]
机构
[1] Kliniken Univ Duisburg Essen, LVR Klinikum Essen, Klin Abhangiges Verhalten & Suchtmed, D-45174 Essen, Germany
关键词
opiate dependence; contingency management; comorbid substance-related disorders; psychotherapy; DRUG-ABUSE TREATMENT; METHADONE-MAINTENANCE TREATMENT; VOUCHER-BASED REINFORCEMENT; COCAINE ABSTINENCE; DEPENDENT PATIENTS; RANDOMIZED-TRIAL; MULTIPLE-DRUGS; HEROIN USERS; FOLLOW-UP; OPIATE;
D O I
10.1055/s-0029-1245810
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The majority of opiate-dependent patients in substitution treatment show additional substance-related disorders. Concomitant use of heroin, alcohol, benzodiazepines or cocaine compromises treatment success. Concomitant drug use may be treated by using contingency management (CM) which is based on learning theory. In CM, abstinence from drugs, as verified by drug screenings, is reinforced directly and contingently. Reinforcers used in CM studies with substituted patients were, amongst others, vouchers and take-home privileges. Studies in the USA show a medium average effect of CM on drug consumption rates and abstinence. The effects decrease markedly after the end of the intervention. We discuss whether CM is applicable within the German substitution treatment system and how it can be combined with other interventions such as selective detoxification treatments or cognitive-behavioural programmes.
引用
收藏
页码:395 / 403
页数:9
相关论文
共 50 条
  • [31] Contingency management for treatment of substance abuse
    Stitzer, Maxine
    Petry, Nancy
    [J]. ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, 2006, 2 : 411 - 434
  • [32] Contingency management in substance abuse treatment
    Cameron, Jacqui
    [J]. DRUG AND ALCOHOL REVIEW, 2008, 27 (05) : 572 - 573
  • [33] Therapeutic drug monitoring in the opioid substitution treatment
    Kuzin, M.
    [J]. PHARMACOPSYCHIATRY, 2024, 57 (02) : 88 - 89
  • [34] Drug use and opioid substitution treatment for prisoners
    Heino Stöver
    Ingo Ilja Michels
    [J]. Harm Reduction Journal, 7
  • [35] Opioid substitution and HIV/AIDS treatment and prevention
    Kerr, T
    Wodak, A
    Elliott, R
    Montaner, JS
    Wood, E
    [J]. LANCET, 2004, 364 (9449): : 1918 - 1919
  • [36] Economic evaluation of opioid substitution treatment in Greece
    Geitona, Mary
    Carayanni, Vilelmine
    Petratos, Pythagoras
    [J]. HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2012, 14 (03) : 77 - 88
  • [37] Injectable heroin substitution treatment for opioid dependency
    Drucker, E
    [J]. LANCET, 2001, 358 (9291): : 1385 - 1385
  • [38] Opioid substitution therapy: Lowering the treatment thresholds
    Kourounis, Georgios
    Richards, Brian David Wensley
    Kyprianou, Evdokia
    Symeonidou, Eva
    Malliori, Minerva-Melpomeni
    Samartzis, Lampros
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2016, 161 : 1 - 8
  • [39] Drug use and opioid substitution treatment for prisoners
    Stoever, Heino
    Michels, Ingo Ilja
    [J]. HARM REDUCTION JOURNAL, 2010, 7
  • [40] Sustainment of contingency management within opioid treatment programs: COVID-related barriers and innovative workflow adaptations
    Becker, Sara J.
    Bowen, Caitlyn A.
    Reed, Ellaina N.
    Lang, Sharon G.
    Correia, Nicholas
    Yermash, Julia
    Yap, Kimberly R.
    Rash, Carla J.
    Garner, Bryan R.
    [J]. DRUG AND ALCOHOL DEPENDENCE REPORTS, 2021, 1